FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280618832> ?p ?o ?g. }

• W4280618832 endingPage "103624" @default.
• W4280618832 startingPage "103624" @default.
• W4280618832 abstract "Introduction: Multiple sclerosis (MS) is a chronic demyelination disease of the central nervous system (CNS) that attacks the myelin sheath around the axon and damages it. Therefore, promoting remyelination is a critical strategy for treating MS to resolve and alleviate symptoms and protect myelin sheath from further damage. Vitamin D3 (Vit D3) supplementation is increasingly advised to patients with MS. Thus, this study aimed to investigate the effects of Vit D3 supplementation to improve remyelination in a cuprizone (CPZ) mouse model of MS.Material(s) and Method(s): The study was designed as two stages (de and re-myelination) for nine weeks; a total of 45 male SWR/J mice were divided into two groups, Control (n=15) and CPZ (n=30) groups for the first five weeks (demyelination stage). Mice in the control group were received a normal diet with ad libitum access through all experiment stages (de and re-myelination), whereas mice in the CPZ group were fed a diet mixed with 0.3% CPZ for 5 weeks to induce demyelination. After week 5 CPZ diet was discontinued and followed by a normal diet for the last 4 weeks (remyelination stages), and mice in the CPZ group were re-divided into two groups: untreated and treated with Vit D3 orally once daily at 800 IU/kg. The effect of Vit D3 on behavioral changes was determined using grip strength meter and rotarod test. The degree of de and re-myelination in the corpus callosum (CC) of brains were assessed by Luxol Fast Blue (LFB) stain at weeks 5, 7, and 9.Result(s): The results showed that CPZ significantly reduced behavior performance in mice and myelin content in CC during the demyelination stage. In contrast, mice's grip strength and motor coordination performance revealed significantly improved behavior after treatment with Vit D3 at early and last remyelination stages (7 and 9 weeks, respectively). Furthermore, LFB staining showed that Vit D3 significantly promoted remyelination in the CC of the brain compared to the untreated group at the remyelination stages.Conclusion(s): In conclusion, these results demonstrated that Vit D3 could improve remyelination in a CPZ-demyelinating mouse model of MS. Introduction: Multiple sclerosis (MS) is a chronic demyelination disease of the central nervous system (CNS) that attacks the myelin sheath around the axon and damages it. Therefore, promoting remyelination is a critical strategy for treating MS to resolve and alleviate symptoms and protect myelin sheath from further damage. Vitamin D3 (Vit D3) supplementation is increasingly advised to patients with MS. Thus, this study aimed to investigate the effects of Vit D3 supplementation to improve remyelination in a cuprizone (CPZ) mouse model of MS. Material(s) and Method(s): The study was designed as two stages (de and re-myelination) for nine weeks; a total of 45 male SWR/J mice were divided into two groups, Control (n=15) and CPZ (n=30) groups for the first five weeks (demyelination stage). Mice in the control group were received a normal diet with ad libitum access through all experiment stages (de and re-myelination), whereas mice in the CPZ group were fed a diet mixed with 0.3% CPZ for 5 weeks to induce demyelination. After week 5 CPZ diet was discontinued and followed by a normal diet for the last 4 weeks (remyelination stages), and mice in the CPZ group were re-divided into two groups: untreated and treated with Vit D3 orally once daily at 800 IU/kg. The effect of Vit D3 on behavioral changes was determined using grip strength meter and rotarod test. The degree of de and re-myelination in the corpus callosum (CC) of brains were assessed by Luxol Fast Blue (LFB) stain at weeks 5, 7, and 9. Result(s): The results showed that CPZ significantly reduced behavior performance in mice and myelin content in CC during the demyelination stage. In contrast, mice's grip strength and motor coordination performance revealed significantly improved behavior after treatment with Vit D3 at early and last remyelination stages (7 and 9 weeks, respectively). Furthermore, LFB staining showed that Vit D3 significantly promoted remyelination in the CC of the brain compared to the untreated group at the remyelination stages. Conclusion(s): In conclusion, these results demonstrated that Vit D3 could improve remyelination in a CPZ-demyelinating mouse model of MS." @default.
• W4280618832 created "2022-05-22" @default.
• W4280618832 creator A5013050982 @default.
• W4280618832 creator A5018535034 @default.
• W4280618832 creator A5061634246 @default.
• W4280618832 creator A5074498553 @default.
• W4280618832 date "2022-03-01" @default.
• W4280618832 modified "2023-10-16" @default.
• W4280618832 title "Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone" @default.
• W4280618832 doi "https://doi.org/10.1016/j.msard.2022.103624" @default.
• W4280618832 hasPublicationYear "2022" @default.
• W4280618832 type Work @default.
• W4280618832 citedByCount "0" @default.
• W4280618832 crossrefType "journal-article" @default.
• W4280618832 hasAuthorship W4280618832A5013050982 @default.
• W4280618832 hasAuthorship W4280618832A5018535034 @default.
• W4280618832 hasAuthorship W4280618832A5061634246 @default.
• W4280618832 hasAuthorship W4280618832A5074498553 @default.
• W4280618832 hasBestOaLocation W42806188321 @default.
• W4280618832 hasConcept C124490489 @default.
• W4280618832 hasConcept C126322002 @default.
• W4280618832 hasConcept C134018914 @default.
• W4280618832 hasConcept C142724271 @default.
• W4280618832 hasConcept C203014093 @default.
• W4280618832 hasConcept C2776940978 @default.
• W4280618832 hasConcept C2777619251 @default.
• W4280618832 hasConcept C2777981454 @default.
• W4280618832 hasConcept C2778183499 @default.
• W4280618832 hasConcept C2778609137 @default.
• W4280618832 hasConcept C2780640218 @default.
• W4280618832 hasConcept C2985495968 @default.
• W4280618832 hasConcept C529278444 @default.
• W4280618832 hasConcept C71924100 @default.
• W4280618832 hasConcept C90224389 @default.
• W4280618832 hasConcept C90924648 @default.
• W4280618832 hasConceptScore W4280618832C124490489 @default.
• W4280618832 hasConceptScore W4280618832C126322002 @default.
• W4280618832 hasConceptScore W4280618832C134018914 @default.
• W4280618832 hasConceptScore W4280618832C142724271 @default.
• W4280618832 hasConceptScore W4280618832C203014093 @default.
• W4280618832 hasConceptScore W4280618832C2776940978 @default.
• W4280618832 hasConceptScore W4280618832C2777619251 @default.
• W4280618832 hasConceptScore W4280618832C2777981454 @default.
• W4280618832 hasConceptScore W4280618832C2778183499 @default.
• W4280618832 hasConceptScore W4280618832C2778609137 @default.
• W4280618832 hasConceptScore W4280618832C2780640218 @default.
• W4280618832 hasConceptScore W4280618832C2985495968 @default.
• W4280618832 hasConceptScore W4280618832C529278444 @default.
• W4280618832 hasConceptScore W4280618832C71924100 @default.
• W4280618832 hasConceptScore W4280618832C90224389 @default.
• W4280618832 hasConceptScore W4280618832C90924648 @default.
• W4280618832 hasLocation W42806188321 @default.
• W4280618832 hasOpenAccess W4280618832 @default.
• W4280618832 hasPrimaryLocation W42806188321 @default.
• W4280618832 hasRelatedWork W1976573815 @default.
• W4280618832 hasRelatedWork W2007987691 @default.
• W4280618832 hasRelatedWork W2020375096 @default.
• W4280618832 hasRelatedWork W2022452208 @default.
• W4280618832 hasRelatedWork W2047057461 @default.
• W4280618832 hasRelatedWork W2243144343 @default.
• W4280618832 hasRelatedWork W2570561428 @default.
• W4280618832 hasRelatedWork W2771462734 @default.
• W4280618832 hasRelatedWork W4205593897 @default.
• W4280618832 hasRelatedWork W4311282629 @default.
• W4280618832 hasVolume "59" @default.
• W4280618832 isParatext "false" @default.
• W4280618832 isRetracted "false" @default.
• W4280618832 workType "article" @default.